Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 543

1.

Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.

Dagres N, Varounis C, Flevari P, Piorkowski C, Bode K, Rallidis LS, Tsougos E, Leftheriotis D, Sommer P, Hindricks G, Kremastinos DT.

Am Heart J. 2009 Jul;158(1):15-20. doi: 10.1016/j.ahj.2009.05.012.

PMID:
19540387
2.

Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).

Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale DF.

Eur Heart J. 2006 Jan;27(2):216-21. Epub 2005 Oct 7.

PMID:
16214831
3.

A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.

Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V.

J Am Coll Cardiol. 2006 Dec 5;48(11):2340-7. Epub 2006 Oct 16.

4.

Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone A, Santinelli V, Tortoriello V, Sala S, Zangrillo A, Crescenzi G, Benussi S, Alfieri O.

J Am Coll Cardiol. 2003 Jul 16;42(2):185-97.

5.

A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation.

Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morillo CA.

J Cardiovasc Electrophysiol. 2009 Feb;20(2):138-44. doi: 10.1111/j.1540-8167.2008.01285.x. Epub 2008 Sep 3. Review.

PMID:
18775040
6.

Dronedarone and the incidence of stroke in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials.

Dagres N, Varounis C, Iliodromitis EK, Lekakis JP, Rallidis LS, Anastasiou-Nana M.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):395-400. doi: 10.2165/11594200-000000000-00000. Review.

PMID:
22149318
7.

Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials.

Kong MH, Lopes RD, Piccini JP, Hasselblad V, Bahnson TD, Al-Khatib SM.

Cardiovasc Ther. 2010 Oct;28(5):311-26. doi: 10.1111/j.1755-5922.2010.00139.x. Review.

PMID:
20370795
8.

Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.

Pappone C, Vicedomini G, Augello G, Manguso F, Saviano M, Baldi M, Petretta A, Giannelli L, Calovic Z, Guluta V, Tavazzi L, Santinelli V.

Circ Arrhythm Electrophysiol. 2011 Dec;4(6):808-14. doi: 10.1161/CIRCEP.111.966408. Epub 2011 Sep 23.

PMID:
21946315
9.

Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.

Igarashi M, Tada H, Sekiguchi Y, Yamasaki H, Arimoto T, Kuroki K, Machino T, Murakoshi N, Aonuma K.

Am J Cardiol. 2010 Jul 1;106(1):62-8. doi: 10.1016/j.amjcard.2010.02.016. Epub 2010 May 18.

PMID:
20609649
10.

Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation.

Nademanee K, Schwab MC, Kosar EM, Karwecki M, Moran MD, Visessook N, Michael AD, Ngarmukos T.

J Am Coll Cardiol. 2008 Feb 26;51(8):843-9. doi: 10.1016/j.jacc.2007.10.044.

11.

Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation.

Turco P, De Simone A, La Rocca V, Iuliano A, Capuano V, Astarita C, Di Napoli T, Messina V, Baldi S, Stabile G.

Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S112-5. Erratum in: Pacing Clin Electrophysiol. 2007 Nov;30(11):1424.

PMID:
17302684
12.

Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher.

Lin YJ, Chao TF, Tsao HM, Chang SL, Lo LW, Chiang CE, Hu YF, Hsu PF, Chuang SY, Li CH, Chung FP, Chen YY, Wu TJ, Hsieh MH, Chen SA.

Europace. 2013 May;15(5):676-84. doi: 10.1093/europace/eus336. Epub 2012 Nov 28.

PMID:
23193161
13.

Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy.

Forleo GB, Mantica M, De Luca L, Leo R, Santini L, Panigada S, De Sanctis V, Pappalardo A, Laurenzi F, Avella A, Casella M, Dello Russo A, Romeo F, Pelargonio G, Tondo C.

J Cardiovasc Electrophysiol. 2009 Jan;20(1):22-8. doi: 10.1111/j.1540-8167.2008.01275.x. Epub 2008 Sep 3.

PMID:
18775050
14.

Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis.

Dagres N, Varounis C, Gaspar T, Piorkowski C, Eitel C, Iliodromitis EK, Lekakis JP, Flevari P, Simeonidou E, Rallidis LS, Tsougos E, Hindricks G, Sommer P, Anastasiou-Nana M.

J Card Fail. 2011 Nov;17(11):964-70. doi: 10.1016/j.cardfail.2011.07.009. Epub 2011 Sep 9. Review.

PMID:
22041335
15.

Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.

Saad EB, d'Avila A, Costa IP, Aryana A, Slater C, Costa RE, Inácio LA Jr, Maldonado P, Neto DM, Camiletti A, Camanho LE, Polanczyk CA.

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):615-21. doi: 10.1161/CIRCEP.111.963231. Epub 2011 Aug 13.

PMID:
21841192
16.

Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review.

Noheria A, Kumar A, Wylie JV Jr, Josephson ME.

Arch Intern Med. 2008 Mar 24;168(6):581-6. doi: 10.1001/archinte.168.6.581. Review.

PMID:
18362249
17.

Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials.

Zheng YR, Chen ZY, Ye LF, Wang LH.

J Geriatr Cardiol. 2015 Sep;12(5):507-14. doi: 10.11909/j.issn.1671-5411.2015.05.012.

18.

Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.

de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA.

Arch Intern Med. 2005 Feb 14;165(3):258-62. Review.

PMID:
15710787
19.

Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials.

Bonanno C, Paccanaro M, La Vecchia L, Ometto R, Fontanelli A.

J Cardiovasc Med (Hagerstown). 2010 Jun;11(6):408-18. doi: 10.2459/JCM.0b013e328332e926. Review.

PMID:
19834326
20.

Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.

Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day JD.

J Cardiovasc Electrophysiol. 2009 Sep;20(9):988-93. doi: 10.1111/j.1540-8167.2009.01481.x. Epub 2009 May 15.

PMID:
19473299

Supplemental Content

Support Center